Enterprise Leader logo

The Latest Headlines at Enterprise Leader

Image about Wells Fargo & Company Increases Occidental Petroleum (NYSE:OXY) Price Target to $69.00

Wells Fargo & Company Increases Occidental Petroleum (NYSE:OXY) Price Target to $69.00

Occidental Petroleum (NYSE:OXY – Get Free Report) had its target price lifted by Wells Fargo & Company from $68.00 to $69.00 in a note issued to investors on Friday, Benzinga reports. The firm currently has an “equal... More of this article »
Image about Sarepta Therapeutics (NASDAQ:SRPT) Given New $235.00 Price Target at Needham & Company LLC

Sarepta Therapeutics (NASDAQ:SRPT) Given New $235.00 Price Target at Needham & Company LLC

Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) had its target price upped by stock analysts at Needham & Company LLC from $166.00 to $235.00 in a report released on Friday, Benzinga reports. The firm presently has... More of this article »
Image about Head-To-Head Review: Japan Tobacco (OTCMKTS:JAPAY) and Bayerische Motoren Werke Aktiengesellschaft (OTCMKTS:BAMXF)

Head-To-Head Review: Japan Tobacco (OTCMKTS:JAPAY) and Bayerische Motoren Werke Aktiengesellschaft (OTCMKTS:BAMXF)

Bayerische Motoren Werke Aktiengesellschaft (OTCMKTS:BAMXF – Get Free Report) and Japan Tobacco (OTCMKTS:JAPAY – Get Free Report) are both auto/tires/trucks companies, but which is the superior investment? We will compare... More of this article »
Image about Evercore ISI Boosts Longboard Pharmaceuticals (NASDAQ:LBPH) Price Target to $57.00

Evercore ISI Boosts Longboard Pharmaceuticals (NASDAQ:LBPH) Price Target to $57.00

Longboard Pharmaceuticals (NASDAQ:LBPH – Free Report) had its price target hoisted by Evercore ISI from $44.00 to $57.00 in a research note issued to investors on Thursday, Benzinga reports. The firm currently has an outperform... More of this article »
Image about Stifel Nicolaus Lowers Darden Restaurants (NYSE:DRI) Price Target to $180.00

Stifel Nicolaus Lowers Darden Restaurants (NYSE:DRI) Price Target to $180.00

Darden Restaurants (NYSE:DRI – Get Free Report) had its target price cut by Stifel Nicolaus from $190.00 to $180.00 in a research report issued on Friday, Benzinga reports. The firm presently has a “buy” rating on... More of this article »
Image about Genocea Biosciences (NASDAQ:GNCA) Coverage Initiated at StockNews.com

Genocea Biosciences (NASDAQ:GNCA) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Free Report) in a research report sent to investors on Wednesday. The firm issued a sell rating on the biotechnology company’s stock. Genocea... More of this article »
Image about Nexstar Media Group (NASDAQ:NXST) Earns Buy Rating from Benchmark

Nexstar Media Group (NASDAQ:NXST) Earns Buy Rating from Benchmark

Benchmark restated their buy rating on shares of Nexstar Media Group (NASDAQ:NXST – Free Report) in a research note issued to investors on Thursday morning, Benzinga reports. They currently have a $225.00 price objective on... More of this article »
Image about Paylocity (NASDAQ:PCTY) PT Lowered to $153.00 at TD Cowen

Paylocity (NASDAQ:PCTY) PT Lowered to $153.00 at TD Cowen

Paylocity (NASDAQ:PCTY – Free Report) had its target price decreased by TD Cowen from $180.00 to $153.00 in a research report sent to investors on Thursday morning, Benzinga reports. TD Cowen currently has a buy rating on the... More of this article »
Image about MKS Instruments (NASDAQ:MKSI) Earns Hold Rating from Deutsche Bank Aktiengesellschaft

MKS Instruments (NASDAQ:MKSI) Earns Hold Rating from Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft restated their hold rating on shares of MKS Instruments (NASDAQ:MKSI – Free Report) in a research report report published on Thursday morning, MarketBeat Ratings reports. The brokerage currently... More of this article »
Image about iPower (NYSE:IPW) vs. ZKH Group (NYSE:ZKH) Head to Head Comparison

iPower (NYSE:IPW) vs. ZKH Group (NYSE:ZKH) Head to Head Comparison

ZKH Group (NYSE:ZKH – Get Free Report) and iPower (NYSE:IPW – Get Free Report) are both small-cap business services companies, but which is the superior business? We will contrast the two businesses based on the strength... More of this article »
Image about YS Biopharma (NASDAQ:YS) versus Abeona Therapeutics (NASDAQ:ABEO) Financial Comparison

YS Biopharma (NASDAQ:YS) versus Abeona Therapeutics (NASDAQ:ABEO) Financial Comparison

YS Biopharma (NASDAQ:YS – Get Free Report) and Abeona Therapeutics (NASDAQ:ABEO – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength... More of this article »
Image about Edesa Biotech (NASDAQ:EDSA) versus Assertio (NASDAQ:ASRT) Critical Comparison

Edesa Biotech (NASDAQ:EDSA) versus Assertio (NASDAQ:ASRT) Critical Comparison

Edesa Biotech (NASDAQ:EDSA – Get Free Report) and Assertio (NASDAQ:ASRT – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of... More of this article »
Image about Contrasting JinkoSolar (NYSE:JKS) and Oxford Instruments (OTCMKTS:OXINF)

Contrasting JinkoSolar (NYSE:JKS) and Oxford Instruments (OTCMKTS:OXINF)

JinkoSolar (NYSE:JKS – Get Free Report) and Oxford Instruments (OTCMKTS:OXINF – Get Free Report) are both small-cap oils/energy companies, but which is the superior business? We will contrast the two companies based on... More of this article »
Image about Rivian Automotive, Inc. (NASDAQ:RIVN) Given Consensus Rating of “Moderate Buy” by Analysts

Rivian Automotive, Inc. (NASDAQ:RIVN) Given Consensus Rating of “Moderate Buy” by Analysts

Rivian Automotive, Inc. (NASDAQ:RIVN – Get Free Report) has received a consensus rating of “Moderate Buy” from the twenty-four ratings firms that are covering the company, Marketbeat Ratings reports. One investment... More of this article »
Image about Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Receives Average Rating of “Hold” from Brokerages

Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Receives Average Rating of “Hold” from Brokerages

Shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) have earned an average recommendation of “Hold” from the six analysts that are currently covering the firm, Marketbeat reports. Six analysts have... More of this article »